Showing results (221-230 of 2,337) with videos related to
Sort By:
Pageof 234
Clinical Lung Cancer|July 19, 2016
Prognostic Factor Analysis in Patients With Small-Cell Lung Cancer Treated With Third-Line ChemotherapyKoichi Saruwatari, Shigeki Umemura, Shogo Nomura, et al.Clinical Lung Cancer|July 19, 2016
Primary Tumor Location Is a Useful Predictor for Lymph Node Metastasis and Prognosis in Lung AdenocarcinomaWei Sun, Xin Yang, Yu Liu, et al.Clinical Lung Cancer|May 25, 2015
Preliminary Safety, Pharmacokinetics, and Efficacy of Regorafenib, Cisplatin, and Pemetrexed in Patients With Advanced Nonsquamous Non-Small-Cell Lung CancersMatthew D Hellmann, Isrid Sturm, Zuzana Jirakova Trnkova, et al.Clinical Lung Cancer|June 22, 2015
CHAMP: A Phase II Study of Panitumumab With Pemetrexed and Cisplatin Versus Pemetrexed and Cisplatin in the Treatment of Patients With Advanced-Stage Primary Nonsquamous Non-Small-Cell Lung Cancer With Particular Regard to the KRAS StatusWolfgang Schuette, Dirk Behringer, Jan Stoehlmacher, et al.Clinical Lung Cancer|July 13, 2015
Ratio of Lymph Node to Primary Tumor SUV on PET/CT Accurately Predicts Nodal Malignancy in Non-Small-Cell Lung CancerMalcolm D Mattes, Ariella B Moshchinsky, Salma Ahsanuddin, et al.Clinical Lung Cancer|July 28, 2016
Immunotherapy Comes of Age in Lung CancerPriyanka Khanna, Normand Blais, Pierre-Olivier Gaudreau, et al.Clinical Lung Cancer|April 11, 2020
A Subsolid Nodules Imaging Reporting System (SSN-IRS) for Classifying 3 Subtypes of Pulmonary AdenocarcinomaXiaonan Cui, Marjolein A Heuvelmans, Shuxuan Fan, et al.Clinical Lung Cancer|April 11, 2020
Hazards of Recurrence, Second Primary, or Other Tumor at Ten Years After Surgery for Non-Small-Cell Lung CancerNicole Fink-Neuboeck, Joerg Lindenmann, Christian Porubsky, et al.Clinical Lung Cancer|July 28, 2006
Current status of adjuvant chemotherapy for stage IB non-small-cell lung cancer: implications for the New Intergroup TrialHeather A Wakelee, Joan H Schiller, David R GandaraClinical Lung Cancer|July 28, 2006
DNA methyltransferases messenger RNA expression and aberrant methylation of CpG islands in non-small-cell lung cancer: association and prognostic valueDaniel Vallböhmer, Jan Brabender, Dongyun Yang, et al.Pageof 234